Disc Medicine (IRON) Misses Q2 EPS by 46c
Get Alerts IRON Hot Sheet
Join SI Premium – FREE
Disc Medicine (NASDAQ: IRON) reported Q2 EPS of ($1.58), $0.46 worse than the analyst estimate of ($1.12).
For earnings history and earnings-related data on Disc Medicine (IRON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Kanen Wealth Management urges Zevia to explore a sale
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share